Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like FDA is Firm on Keeping GCP Inspections In Person February 16, 2022 Administration May Target Medicare Part B and D Plans in Efforts to Lower Drug Costs May 14, 2018 Drugmakers Seek More Details on LPAD Pathway Draft Guidance August 15, 2018